» Articles » PMID: 29899246

FADS Polymorphism, Omega-3 Fatty Acids and Diabetes Risk: A Systematic Review

Overview
Journal Nutrients
Date 2018 Jun 15
PMID 29899246
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

The role of 3 long chain polyunsaturated fatty acids (LC 3 PUFA) in reducing the risk of type 2 diabetes (T2DM) is not well established. The synthesis of LC 3 PUFA requires fatty acid desaturase enzymes, which are encoded by the FADS gene. It is unclear if FADS polymorphism and dietary fatty acid intake can influence plasma or erythrocyte membrane fatty acid profile and thereby the risk of T2DM. Thus, the aim of this systematic review was to assess the current evidence for an effect of FADS polymorphism on T2DM risk and understand its associations with serum/erythrocyte and dietary LC 3 PUFA. A systematic search was performed using PubMed, Embase, Cochrane and Scopus databases. A total of five studies met the inclusion criteria and were included in the present review. This review identified that FADS polymorphism may alter plasma fatty acid composition and play a protective role in the development of T2DM. Serum and erythrocyte LC 3 PUFA levels were not associated with risk of T2DM, while dietary intake of LC 3 PUFA was associated with lower risk of T2DM in one study only. The effect of LC 3 PUFA consumption on associations between FADS polymorphism and T2DM warrants further investigation.

Citing Articles

Genetic association between FADS and ELOVL polymorphisms and the circulating levels of EPA/DHA in humans: a scoping review.

Loukil I, Mutch D, Plourde M Genes Nutr. 2024; 19(1):11.

PMID: 38844860 PMC: 11157910. DOI: 10.1186/s12263-024-00747-4.


Relationship between gene rs780094 polymorphism and type 2 diabetes with albuminuria.

Liu Y, Wan Q World J Diabetes. 2024; 14(12):1803-1812.

PMID: 38222779 PMC: 10784796. DOI: 10.4239/wjd.v14.i12.1803.


Metabolomic epidemiology offers insights into disease aetiology.

Fuller H, Zhu Y, Nicholas J, Chatelaine H, Drzymalla E, Sarvestani A Nat Metab. 2023; 5(10):1656-1672.

PMID: 37872285 PMC: 11164316. DOI: 10.1038/s42255-023-00903-x.


New Perspectives on the Associations between Blood Fatty Acids, Growth Parameters, and Cognitive Development in Global Child Populations.

Cardino V, Goeden T, Yakah W, Ezeamama A, Fenton J Nutrients. 2023; 15(8).

PMID: 37111152 PMC: 10143140. DOI: 10.3390/nu15081933.


Metabolic Signatures Elucidate the Effect of Body Mass Index on Type 2 Diabetes.

Dong Q, Sidra S, Gieger C, Wang-Sattler R, Rathmann W, Prehn C Metabolites. 2023; 13(2).

PMID: 36837846 PMC: 9965667. DOI: 10.3390/metabo13020227.


References
1.
Simopoulos A . Genetic variants in the metabolism of omega-6 and omega-3 fatty acids: their role in the determination of nutritional requirements and chronic disease risk. Exp Biol Med (Maywood). 2010; 235(7):785-95. DOI: 10.1258/ebm.2010.009298. View

2.
Hivert M, Vassy J, Meigs J . Susceptibility to type 2 diabetes mellitus--from genes to prevention. Nat Rev Endocrinol. 2014; 10(4):198-205. PMC: 4058643. DOI: 10.1038/nrendo.2014.11. View

3.
Chen C, Yu X, Shao S . Effects of Omega-3 Fatty Acid Supplementation on Glucose Control and Lipid Levels in Type 2 Diabetes: A Meta-Analysis. PLoS One. 2015; 10(10):e0139565. PMC: 4591987. DOI: 10.1371/journal.pone.0139565. View

4.
Moloney F, Yeow T, Mullen A, Nolan J, Roche H . Conjugated linoleic acid supplementation, insulin sensitivity, and lipoprotein metabolism in patients with type 2 diabetes mellitus. Am J Clin Nutr. 2004; 80(4):887-95. DOI: 10.1093/ajcn/80.4.887. View

5.
Calder P . Mechanisms of action of (n-3) fatty acids. J Nutr. 2012; 142(3):592S-599S. DOI: 10.3945/jn.111.155259. View